Cyclosporine Export Market Intelligence: India's 177 Suppliers Shipping to 100 Countries — TransData Nexus 2026

Q: Who are the top cyclosporine exporters from India?

The top cyclosporine exporters from India are: 1. STRIDES PHARMA SCIENCE LIMITED — $3.2M (26.7% market share); 2. CONCORD BIOTECH LIMITED — $2.4M (19.6% market share); 3. PANACEA BIOTEC PHARMA LIMITED — $1.7M (13.7% market share); 4. STARCELL BIOTECH LLP — $579.4K (4.8% market share); 5. MODERN DRUG HOUSE — $484.4K (4.0% market share). Together they account for 68.7% of India's total cyclosporine export value.

Q: What is the total export value of cyclosporine from India?

The total export value of cyclosporine from India is $12.1M USD, recorded across 2,531 shipment transactions from 177 active exporters to 100 destination countries. The average shipment value is $4.8K.

Q: Which countries import cyclosporine from India?

India exports cyclosporine to 100 countries worldwide. The top importing countries are: UNITED STATES (26.8% share, $3.2M), TURKEY (22.6% share, $2.7M), ECUADOR (10.4% share, $1.3M), UNITED ARAB EMIRATES (8.2% share, $992.0K), SAUDI ARABIA (4.8% share, $581.3K). These five markets account for 72.7% of total export value.

Q: What is the HS code for cyclosporine exports from India?

The primary HS code for cyclosporine exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of cyclosporine exports from India?

The average unit price for cyclosporine exports from India is $14.74 USD per unit, with prices ranging from $0.01 to $2353.69 depending on formulation, packaging, and order volume. The total market is valued at $12.1M across 2,531 shipments.

Q: Which ports handle cyclosporine exports from India?

The primary ports for cyclosporine exports from India are SAHAR AIR (31.9% of shipments), SAHAR AIR CARGO ACC (INBOM4) (17.2% of shipments), DELHI AIR CARGO ACC (INDEL4) (11.5% of shipments), DELHI AIR (8.7% of shipments), Bombay Air (6.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of cyclosporine?

India is one of the world's leading exporters of cyclosporine due to its large base of 177 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports cyclosporine to 100 countries, demonstrating 51% global market coverage.

Q: What certifications do Indian cyclosporine exporters need?

Indian cyclosporine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import cyclosporine from India?

There are 319 registered buyers importing cyclosporine from India, spread across 100 countries. The repeat buyer rate is 62.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top cyclosporine supplier from India?

STRIDES PHARMA SCIENCE LIMITED is the leading cyclosporine exporter from India with a market share of 26.7% and total export value of $3.2M across 62 shipments. The top 5 suppliers together control 68.7% of total export value.

Suresh Sormare

Cyclosporine

India Pharmaceutical Trade Intelligence

$12.1M177 Suppliers100 CountriesHS 30049099

ExportsIndia → UNITED STATES26.8%India → TURKEY22.6%

ImportsFRANCE → India$28.8M UNITED STATES → India$2.0M

#1 Supplier: STRIDES PHARMA

Cyclosporine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Cyclosporine to the World

Between 2022 and 2026, India exported $12.1M worth of cyclosporine across 2,531 verified shipments to 100 countries — covering 51% of world markets in the Immunosuppressants segment. The largest destination is UNITED STATES (26.8%). STRIDES PHARMA SCIENCE LIMITED leads with a 26.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Cyclosporine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Cyclosporine export data snapshot — $12.1M · 177 exporters · 100 countriesTransData Nexus · Indian Customs Data

Top Cyclosporine Exporters from India

177 active exporters · Ranked by export value

View all 177 →

Top Cyclosporine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	STRIDES PHARMA SCIENCE LIMITED	$3.2M	62	2	26.7%
2	CONCORD BIOTECH LIMITED

Top Countries Importing Cyclosporine from India

100 destination markets · Ranked by import value

All 100 countries →

Top Countries Importing Cyclosporine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$3.2M	26.8%
2	TURKEY	$2.7M	22.6%
3	ECUADOR	$1.3M	10.4%
4	UNITED ARAB EMIRATES	$992.0K	8.2%
5	SAUDI ARABIA	$581.3K	4.8%
6	MAURITIUS	$365.3K	3.0%
7	SRI LANKA	$299.8K	2.5%
8	JORDAN	$283.8K	2.3%
9	YEMEN	$262.3K	2.2%
10	SPAIN	$206.4K	1.7%

UNITED STATES is India's largest cyclosporine export destination, absorbing 26.8% of total exports worth $3.2M. The top 5 importing countries — UNITED STATES, TURKEY, ECUADOR, UNITED ARAB EMIRATES, SAUDI ARABIA — together account for 72.7% of India's total cyclosporine export value. The remaining 95 destination countries collectively receive the other 27.3%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Cyclosporine to India?

9 origin countries · Total import value: $31.7M

India imports cyclosporine from 9 countries with a combined import value of $31.7M. The largest supplier is FRANCE ($28.8M, 37 shipments), followed by UNITED STATES and GERMANY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Cyclosporine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	FRANCE	$28.8M	37	91.1%
2	UNITED STATES	$2.0M	78	6.2%
3	GERMANY	$480.8K	49	1.5%
4	SWITZERLAND	$350.0K	6	1.1%
5	CANADA	$29.6K	7	0.1%
6	UNITED KINGDOM	$9.6K	13	0.0%
7	CHINA	$477	2	0.0%
8	SOUTH KOREA	$36	2	0.0%
9	ITALY	$35	1	0.0%

FRANCE is the largest supplier of cyclosporine to India, accounting for 91.1% of total import value. The top 5 origin countries — FRANCE, UNITED STATES, GERMANY, SWITZERLAND, CANADA — together supply 100.0% of India's cyclosporine imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Cyclosporine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Cyclosporine, an immunosuppressant used primarily in organ transplantation and certain autoimmune disorders, is extensively regulated by the U.S. Food and Drug Administration (FDA). The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for cyclosporine, indicating a competitive generic market. Recent approvals include [specific ANDA numbers and approval dates], reflecting ongoing market entries.

As of March 2026, there are no active FDA import alerts specifically targeting cyclosporine products from India. However, manufacturers must remain vigilant, as the FDA routinely updates import alerts to address compliance issues. For instance, Import Alert 66-66, issued in October 2024, pertains to active pharmaceutical ingredients (APIs) that appear misbranded due to labeling violations, underscoring the importance of adherence to FDA labeling requirements.

Given that 26.8% of India's cyclosporine exports are destined for the United States, it is imperative for Indian exporters to ensure compliance with FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), cyclosporine is subject to stringent regulatory oversight. The European Medicines Agency (EMA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) require comprehensive marketing authorization applications demonstrating quality, safety, and efficacy. EU Good Manufacturing Practice (GMP) guidelines mandate that manufacturers adhere to high standards in production processes. Notably, in April 2009, the EMA suspended the marketing authorization for Ciclosporin IDL due to concerns over its benefit-risk balance. (ema.europa.eu)

3WHO Essential Medicines & Global Standards

Cyclosporine is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its critical role in healthcare. The drug is also subject to international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across different markets.

4India Regulatory Classification

In India, cyclosporine is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing to ensure affordability. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC), ensuring that domestic supply is not adversely affected by international demand.

5Patent & Exclusivity Status

The primary patents for cyclosporine have expired, leading to a robust generic market. This has resulted in increased competition among manufacturers, contributing to the drug's affordability and accessibility globally.

6Recent Industry Developments

In August 2025, the NPPA revised the ceiling price for cyclosporine formulations, reflecting changes in production costs and market dynamics. In October 2025, the EMA updated its guidelines on immunosuppressive therapies, including cyclosporine, to enhance patient safety and therapeutic efficacy. In December 2025, the WHO included cyclosporine in its updated Model List of Essential Medicines, reaffirming its importance in global health.

These developments highlight the dynamic regulatory environment surrounding cyclosporine, emphasizing the need for manufacturers and exporters to stay informed and compliant with evolving standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Cyclosporine

Retail & reference prices across 9 markets vs. India FOB export price of $14.74/unit

Global Price Benchmark for Cyclosporine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$41.25	USD	According to the FDA's Orange Book, Cyclosporine is approved for use in the United States.
United Kingdom	$4.90	GBP	The UK's National Health Service (NHS) includes Cyclosporine in its Drug Tariff, indicating its availability and regulated pricing within the NHS framework.
Germany	$13.30	EUR	The German Federal Institute for Drugs and Medical Devices (BfArM) regulates the pricing and availability of Cyclosporine within the country.
Australia

Supply Chain Risk Assessment — Cyclosporine

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Cyclosporine, an immunosuppressant critical for organ transplant patients, is predominantly manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. This dependency exposes the supply chain to potential disruptions stemming from geopolitical tensions, trade restrictions, or production issues within China. For instance, in November 2025, the Indian government reopened the Production Linked Incentive (PLI) scheme to bolster domestic manufacturing of critical APIs and reduce reliance on imports.

Despite these initiatives, the transition to self-sufficiency is gradual. As of December 2025, the PLI scheme has led to the establishment of manufacturing capacities for 26 KSMs and APIs, resulting in cumulative sales of ₹2,315 crore and avoiding imports worth ₹1,807 crore. However, the complete localization of Cyclosporine's KSMs remains a work in progress, leaving the supply chain vulnerable to external shocks.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters account for 68.7% of Cyclosporine exports, with STRIDES PHARMA SCIENCE LIMITED alone contributing 26.7%. This high concentration poses a significant risk; any operational or financial issues within these key suppliers could disrupt global supply chains.

Access Complete Cyclosporine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,531 transactions across 100 markets.

Request Demo View Pricing

Frequently Asked Questions — Cyclosporine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top cyclosporine exporters from India?

The leading cyclosporine exporters from India are STRIDES PHARMA SCIENCE LIMITED, CONCORD BIOTECH LIMITED, PANACEA BIOTEC PHARMA LIMITED, and 10 others. STRIDES PHARMA SCIENCE LIMITED leads with 26.7% market share ($3.2M). The top 5 suppliers together control 68.7% of total export value.

What is the total export value of cyclosporine from India?

The total export value of cyclosporine from India is $12.1M, recorded across 2,531 shipments from 177 active exporters to 100 countries. The average shipment value is $4.8K.

Which countries import cyclosporine from India?

India exports cyclosporine to 100 countries. The top importing countries are UNITED STATES (26.8%), TURKEY (22.6%), ECUADOR (10.4%), UNITED ARAB EMIRATES (8.2%), SAUDI ARABIA (4.8%), which together account for 72.7% of total export value.

What is the HS code for cyclosporine exports from India?

The primary HS code for cyclosporine exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Cyclosporine

Cyclosporine

Top Cyclosporine Exporters from India

Top Countries Importing Cyclosporine from India

Who Supplies Cyclosporine to India?

Quick Facts

Related Immunosuppressants

Related Analysis

Need Details?

Regulatory Landscape — Cyclosporine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Cyclosporine

Supply Chain Risk Assessment — Cyclosporine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Cyclosporine Trade Intelligence

Frequently Asked Questions — Cyclosporine Exports from India

Who are the top cyclosporine exporters from India?

What is the total export value of cyclosporine from India?

Which countries import cyclosporine from India?

What is the HS code for cyclosporine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of cyclosporine exports from India?

Which ports handle cyclosporine exports from India?

Why is India a leading exporter of cyclosporine?

What certifications do Indian cyclosporine exporters need?

How many buyers import cyclosporine from India?

What is the market share of the top cyclosporine exporter from India?

Analysis Methodology